Evidence map›Paper›PMID 26520413›Full record

Trial reportContemporary clinical trials2015

The effect of prebiotic supplementation with inulin on cardiometabolic health: Rationale, design, and methods of a controlled feeding efficacy trial in adults at risk of type 2 diabetes.

Cassie M Mitchell, Brenda M Davy, Tanya M Halliday, Mathew W Hulver, Andrew P Neilson, Monica A Ponder, Kevin P Davy

Open access · greenAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Contemporary clinical trials, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed, 1 pooled it
3.2field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 1 synthesis or guideline pooled it, 59 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Dietary fiber intake and gallstones: The mediating role of serum lipids.The Journal of international medical research · 2026
    Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. Article
  10. Review
  11. Article
  12. Review
  13. Review
  14. Review
  15. Review
  16. Article
  17. The Related Metabolic Diseases and Treatments of Obesity.Healthcare (Basel, Switzerland) · 2022
    Review
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Cassie M MitchellDepartment of Human Nutrition, Foods, and Exercise, Virginia Tech, Blacksburg, VA 24060, USA; Fralin Translational Obesity Research Center, Virginia Tech, Blacksburg, VA 24060, USA.
Brenda M DavyDepartment of Human Nutrition, Foods, and Exercise, Virginia Tech, Blacksburg, VA 24060, USA; Fralin Translational Obesity Research Center, Virginia Tech, Blacksburg, VA 24060, USA.
Tanya M HallidayDepartment of Human Nutrition, Foods, and Exercise, Virginia Tech, Blacksburg, VA 24060, USA; Fralin Translational Obesity Research Center, Virginia Tech, Blacksburg, VA 24060, USA.
Mathew W HulverDepartment of Human Nutrition, Foods, and Exercise, Virginia Tech, Blacksburg, VA 24060, USA; The Metabolic Phenotyping Core at Virginia Tech, Blacksburg, VA 24060, USA; Fralin Translational Obesity Research Center, Virginia Tech, Blacksburg, VA 24060, USA.
Andrew P NeilsonThe Department of Food Science and Technology, Blacksburg, VA 24060, USA; The Metabolic Phenotyping Core at Virginia Tech, Blacksburg, VA 24060, USA; Fralin Translational Obesity Research Center, Virginia Tech, Blacksburg, VA 24060, USA.
Monica A PonderThe Department of Food Science and Technology, Blacksburg, VA 24060, USA; Fralin Translational Obesity Research Center, Virginia Tech, Blacksburg, VA 24060, USA.
Kevin P DavyDepartment of Human Nutrition, Foods, and Exercise, Virginia Tech, Blacksburg, VA 24060, USA; The Metabolic Phenotyping Core at Virginia Tech, Blacksburg, VA 24060, USA; Fralin Translational Obesity Research Center, Virginia Tech, Blacksburg, VA 24060, USA. Electronic address: kdavy@vt.edu.
Virginia Tech · US

Funding

Prebiotics, Gut Microbiota, and Cardiometabolic HealthR21HL118668 · NHLBI · VIRGINIA POLYTECHNIC INST AND ST UNIV · PI DAVY, KEVIN P · 2014 to 2015
$586k
NHLBI NIH HHS R21 HL118668NHLBI NIH HHS R21 HL118668S
6 · The paper itself

Abstract

Prediabetes is associated with low-grade chronic inflammation that increases the risk for developing type 2 diabetes (T2D) and cardiovascular disease (CVD). An elevated lipopolysaccharide concentration, associated with dysbiosis of the intestinal microbiota, has been implicated in the development of both T2D and CVD. Selective modulation of the intestinal microbiota with prebiotics reduces intestinal permeability and endotoxin concentrations, inflammation, and metabolic dysfunction in rodents. The effect of prebiotic supplementation on cardio-metabolic function in humans at risk for T2D is not known. The primary aim of this trial is to determine the influence of prebiotic supplementation with inulin on insulin sensitivity and skeletal muscle metabolic flexibility in adults at risk for T2D. We hypothesize that prebiotic supplementation with inulin will improve insulin sensitivity and skeletal muscle metabolic flexibility. We will randomize 48 adults (40-75 yrs) with prediabetes or a score ≥ 5 on the American Diabetes Association (ADA) risk screener to 6 weeks of prebiotic supplementation with inulin (10 g/day) or placebo. Subjects will be provided with all food for the duration of the study, to avoid potential confounding through differences in dietary intake between individuals. Intestinal permeability, serum endotoxin concentrations, insulin sensitivity, skeletal muscle metabolic flexibility, endothelial function, arterial stiffness, and fecal bacterial composition will be measured at baseline and following treatment. The identification of prebiotic supplementation with inulin as an efficacious strategy for reducing cardio-metabolic risk in individuals at risk of T2D could impact clinical practice by informing dietary recommendations and increasing acceptance of prebiotics by the scientific and medical community.

Indexed as

Dietary SupplementsAdultAgedCardiovascular DiseasesDiabetes Mellitus, Type 2DietEndotoxinsFecesFemaleGastrointestinal AbsorptionHumansInsulin ResistanceInulinMaleMiddle AgedMuscle, SkeletalEndotoxinsInulinPrebioticsCardiovascular diseaseDiabetesDietMicrobiomePrebiotics

Identifiers

PMID26520413
PMCPMC4743874
OpenAlexW2203707862

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.